BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 17435807)

  • 1. [Tuberous sclerosis complex].
    Brandt-Hansen P; Solhoff R
    Tidsskr Nor Laegeforen; 2007 Mar; 127(7):870-3. PubMed ID: 17435807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tuberous sclerosis genes and regulation of the cyclin-dependent kinase inhibitor p27.
    Rosner M; Freilinger A; Hengstschläger M
    Mutat Res; 2006 Sep; 613(1):10-6. PubMed ID: 16713332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
    Mizuguchi M
    Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical symptoms of tuberous sclerosis complex in patients with an identical TSC2 mutation.
    Rok P; Kasprzyk-Obara J; Domańska-Pakieła D; Jóźwiak S
    Med Sci Monit; 2005 May; 11(5):CR230-234. PubMed ID: 15874888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberous sclerosis complex and epilepsy: recent developments and future challenges.
    Holmes GL; Stafstrom CE;
    Epilepsia; 2007 Apr; 48(4):617-30. PubMed ID: 17386056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.
    Hung CC; Su YN; Chien SC; Liou HH; Chen CC; Chen PC; Hsieh CJ; Chen CP; Lee WT; Lin WL; Lee CN
    BMC Med Genet; 2006 Sep; 7():72. PubMed ID: 16981987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins interacting with the tuberous sclerosis gene products.
    Rosner M; Freilinger A; Hengstschläger M
    Amino Acids; 2004 Oct; 27(2):119-28. PubMed ID: 15351877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis complex: disease modifiers and treatments.
    Au KS; Ward CH; Northrup H
    Curr Opin Pediatr; 2008 Dec; 20(6):628-33. PubMed ID: 19005330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
    Floricel F; Higaki K; Maki H; Nanba E; Ninomiya H; Ohno K
    Brain Dev; 2007 Sep; 29(8):502-9. PubMed ID: 17376623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tuberous sclerosis genes, TSC1 and TSC2, trigger different gene expression responses.
    Rosner M; Freilinger A; Lubec G; Hengstschläger M
    Int J Oncol; 2005 Nov; 27(5):1411-24. PubMed ID: 16211238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype--phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex.
    Sancak O; Nellist M; Goedbloed M; Elfferich P; Wouters C; Maat-Kievit A; Zonnenberg B; Verhoef S; Halley D; van den Ouweland A
    Eur J Hum Genet; 2005 Jun; 13(6):731-41. PubMed ID: 15798777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland.
    Devlin LA; Shepherd CH; Crawford H; Morrison PJ
    Dev Med Child Neurol; 2006 Jun; 48(6):495-9. PubMed ID: 16700943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex.
    Tarasewicz A; Debska-Slizień A; Konopa J; Zdrojewski Z; Rutkowski B
    Transplant Proc; 2009 Nov; 41(9):3677-82. PubMed ID: 19917366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2: a proteomic approach.
    Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
    Int J Oncol; 2005 Sep; 27(3):831-8. PubMed ID: 16077935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous sclerosis and epilepsy.
    Petrova LD
    Am J Electroneurodiagnostic Technol; 2011 Mar; 51(1):5-15. PubMed ID: 21516926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberous sclerosis complex: a review.
    Leung AK; Robson WL
    J Pediatr Health Care; 2007; 21(2):108-14. PubMed ID: 17321910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex.
    Choi JE; Chae JH; Hwang YS; Kim KJ
    Brain Dev; 2006 Aug; 28(7):440-6. PubMed ID: 16554133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations in 21 patients with tuberous sclerosis complex and variation of tandem splice-acceptor sites in TSC1 exon 14.
    Sasongko TH; Wataya-Kaneda M; Koterazawa K; Gunadi ; Yusoff S; Harahap IS; Lee MJ; Matsuo M; Nishio H
    Kobe J Med Sci; 2008 May; 54(1):E73-81. PubMed ID: 18772611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberous sclerosis complex with polycystic kidney disease of the adult type: the TSC2/ADPKD1 contiguous gene syndrome.
    Bisceglia M; Galliani C; Carosi I; Simeone A; Ben-Dor D
    Int J Surg Pathol; 2008 Oct; 16(4):375-85. PubMed ID: 18611938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.